Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Rotational Guided Growth in Management of Increased Femoral Anteversion

NCT06320769 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06320769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06320769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Rotational Guided Growth in Management of Increased Femoral Anteversion
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
February 20, 2024
Completion date
March 1, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

increased femoral anteversion